Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
SEC registrant with listed symbol(s): JHPCY (OTC), JNGHF (OTC). This is a filing-identity record, not a verified operating-company profile.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- JHPCY, JNGHF [1]
- Listing exchanges
- OTC [1]
- Company / filing name
- Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR [1]
- Business address
- 7 KUNLUNSHAN ROAD, ECONOMIC TECH DEVELOPMENT ZONE, LIANYUNGANG, 222047 [1]
- Incorporation jurisdiction
- China [1]
- Fiscal year end
- December 31 (SEC record) [1]
- CIK
- 0002071868 [1]
Company positioning and business
SEC registrant with listed symbol(s): JHPCY (OTC), JNGHF (OTC). This is a filing-identity record, not a verified operating-company profile. [2]
The SEC classifies Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR under (SIC ). Its reported business address is 7 KUNLUNSHAN ROAD, ECONOMIC TECH DEVELOPMENT ZONE, LIANYUNGANG, 222047. Industry classification does not establish its full product range. [1]
Financial year, securities and disclosures
The SEC submissions record gives Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: JHPCY (OTC), JNGHF (OTC). Multiple symbols may represent different share classes or securities of the same registrant. [2]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Source-verified relationships
Related entities and concepts
Frequently asked questions
Which industry classification does the SEC report for Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR?
The submissions record lists , SIC . [1]
Where can the financial reports of Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR be read?
The financial disclosures section links to collected annual, quarterly and current reports. The SEC source provides the broader filing record. [2]
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR relationship map
Select a node to inspect its relationship and source.
1 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR filing identity and securities ↗
- Exchange / company source ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.